EMERGENT DEVICES, INC.

Emergent Devices, Inc. specializes in the manufacturing and procurement of life-saving pharmaceutical preparations, with a focused expertise in naloxone-based emergency interventions, particularly NARCAN nasal spray. The company delivers FDA-regulated, high-purity opioid reversal medications under strict Good Manufacturing Practices, ensuring compliance with federal pharmacopeial standards. Their technical proficiency spans formulation validation, sterile product handling, and rapid-scale production of intranasal delivery systems, enabling timely deployment in high-risk public safety and emergency response environments. A key differentiator is their ability to rapidly fulfill time-sensitive orders for critical care pharmaceuticals under federal supply chain protocols, demonstrating agility in meeting urgent operational demands. The contractor maintains a consistent partnership with the Department of Homeland Security, supplying naloxone products to support FEMA’s environmental, safety, and health operations, as well as national fentanyl response initiatives. They also serve the Department of Justice with similar emergency pharmaceutical procurement needs, indicating a trusted role in law enforcement overdose mitigation programs. A single award to the Department of Veterans Affairs confirms their capacity to fulfill Federal Supply Schedule requirements for pharmaceuticals, suggesting alignment with VA’s controlled substance distribution frameworks. Emergent Devices operates primarily within NAICS 325412, focusing on the manufacturing of pharmaceutical preparations, with secondary activity in related chemical product manufacturing and retail distribution of medications. Their market positioning centers on emergency pharmacology, specifically opioid reversal agents, serving federal agencies engaged in public health security and crisis response. As a small business structured as a 2L entity based in Plymouth Meeting, Pennsylvania, Emergent Devices operates without federal certifications but maintains a focused, mission-driven presence in the federal pharmaceutical supply chain, specializing in rapid-response drug delivery for high-stakes government operations.